The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC

Background and purpose:  The function of transporters in peripheral blood mononuclear cells (PBMC) has been characterized, but less is known about cytochrome P450 (CYP) enzyme function in these cells. Given that cytokines are dysregulated in many diseases, the purpose of this work was to assess the impact of cytokines on the expression of CYPs, transporters and chemokine receptors in PBMC.

[1]  S. Khoo,et al.  Detection of ABCC2, CYP2B6 and CYP3A4 in human peripheral blood mononuclear cells using flow cytometry. , 2008, Journal of immunological methods.

[2]  S. Khoo,et al.  Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons , 2008, Current opinion in HIV and AIDS.

[3]  R. Callaghan,et al.  Review/Drug Metabolism and Transport: P-glycoprotein: So Many Ways to Turn It On , 2008 .

[4]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[5]  Micheline Piquette-Miller,et al.  Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer , 2008, Drug Metabolism and Disposition.

[6]  K. Saito,et al.  Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[7]  S. Khoo,et al.  Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. , 2007, The Journal of antimicrobial chemotherapy.

[8]  P. Cane,et al.  Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification. , 2007, The Journal of antimicrobial chemotherapy.

[9]  S. Khoo,et al.  Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjects. , 2007, The Journal of antimicrobial chemotherapy.

[10]  K. Faber,et al.  Decreased P‐glycoprotein (P‐gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels , 2007, Inflammatory bowel diseases.

[11]  David S. Miller,et al.  Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier , 2007, Molecular Pharmacology.

[12]  David S. Miller,et al.  Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. , 2007, Molecular pharmacology.

[13]  M. Rose-Zerilli,et al.  Cytokine gene polymorphisms, cancer susceptibility, and prognosis. , 2007, The Journal of nutrition.

[14]  S. Spinler,et al.  Role of P‐glycoprotein in Statin Drug Interactions , 2006, Pharmacotherapy.

[15]  Yoshiya Tanaka,et al.  [Multi-drug resistance in the treatments of autoimmune diseases]. , 2006, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[16]  R. Riley,et al.  Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5 , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  A. Silman,et al.  Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug , 2006, Annals of the rheumatic diseases.

[18]  S. Khoo,et al.  Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP , 2005, AIDS.

[19]  W. Haefeli,et al.  Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. , 2005, Biochemical pharmacology.

[20]  M. Ratajczak,et al.  Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis , 2005, Stem cells.

[21]  D. Brazeau,et al.  Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction , 2005, European Journal of Clinical Pharmacology.

[22]  E. Benedetti,et al.  An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates. , 2005, Transplantation proceedings.

[23]  J. Fellay,et al.  Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients , 2005, European Journal of Clinical Pharmacology.

[24]  S. Khoo,et al.  Intracellular pharmacokinetics of antiretroviral agents. , 2004, Journal of HIV therapy.

[25]  S. Khoo,et al.  Functional Correlation of P-Glycoprotein Expression and Genotype with Expression of the Human Immunodeficiency Virus Type 1 Coreceptor CXCR4 , 2004, Journal of Virology.

[26]  S. Khoo,et al.  Expression of Pregnane-X-Receptor Transcript in Peripheral Blood Mononuclear Cells and Correlation with Mdr1 Mrna , 2004, Antiviral therapy.

[27]  B. Lacour,et al.  Effect of tumor necrosis factor‐α and interferon‐γ on intestinal P‐glycoprotein expression, activity, and localization in Caco‐2 cells , 2004 .

[28]  Y. Becker.  HIV-1 induced AIDS is an Allergy and the Allergen is the Shed gp120 – a Review, Hypothesis, and Implications , 2004, Virus Genes.

[29]  A. Hishida,et al.  Counter-regulatory effects of procalcitonin and indoxyl sulphate on net albumin secretion by cultured rat hepatocytes. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  G. Murray,et al.  Cytochrome P450 enzymes: novel options for cancer therapeutics. , 2004, Molecular cancer therapeutics.

[31]  E. Soto-Vega,et al.  P-glycoprotein in autoimmune diseases. , 2003, Autoimmunity reviews.

[32]  B. Lacour,et al.  Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. , 2004, Journal of pharmaceutical sciences.

[33]  Elizabeth C M de Lange,et al.  Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. , 2004, Advanced drug delivery reviews.

[34]  V. Miller,et al.  Protein binding in antiretroviral therapies. , 2003, AIDS research and human retroviruses.

[35]  M. Cutolo,et al.  Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. , 2002, Rheumatology.

[36]  R. Johnstone,et al.  P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation , 2002, Cell Death and Differentiation.

[37]  U. Hofmann,et al.  Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.

[38]  Oliver Burk,et al.  Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin* , 2001, The Journal of Biological Chemistry.

[39]  A. Pakyz,et al.  Variability in Activity of Hepatic CYP3A4 in Patients Infected with HIV , 2000, Pharmacotherapy.

[40]  J. Farrés,et al.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies , 2000, Annals of the rheumatic diseases.

[41]  J. McCune,et al.  CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo , 1998, Journal of Virology.

[42]  K. Hirsch‐Ernst,et al.  Induction of mdr1b mRNA and P‐glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures , 1998, Journal of cellular physiology.

[43]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[44]  S. Anttila,et al.  Detection of mRNA encoding xenobiotic‐metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes , 1997, Molecular carcinogenesis.

[45]  J. Stevens,et al.  Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[46]  J. Woody,et al.  Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[47]  J. Bartlett,et al.  HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group. , 1996, AIDS.

[48]  S. Zhao,et al.  Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. , 1996, Blood.

[49]  L. Welage,et al.  Alterations in gastric acidity in patients infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  G. Laurent,et al.  Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line. , 1995, Leukemia.

[51]  P. Sonneveld,et al.  High expression of the multidrug resistance‐associated protein (MRP) in chronic and prolymphocytic leukaemia , 1994, British journal of haematology.

[52]  M. Sobieska,et al.  Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis. , 1993, The Journal of rheumatology.

[53]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[54]  M. Sobieska,et al.  Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? , 1993, Annals of the rheumatic diseases.

[55]  J. Thorner,et al.  Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators. , 1992, Endocrine reviews.